John JV McMurray
Dr McMurray is Professor of Medical Cardiology and Deputy Director (Clinical) of the Institute of Cardiovascular and Medical Sciences and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow.
Published: 25 August 2020
In this Educational Symposium from the e-SPACE Heart Failure Global Web-Conference, John McMurray, Mikhail Kosiborod and Avivit Cahn discuss historical data demonstrating the efficacy of SGLT2 inhibitors in HF patients with T2DM, look at data on the use of the agents in non-diabetics and other populations with HFrEF in regards to the DAPA-HF study; and assess how SGLT2 inhibitors should be incorporated within the context of existing therapies in the HFrEF landscape.
Welcome & IntroductionsWatch now
SGLT2 in Prevention of Heart FailureWatch now
DAPA-HF ‘Deep Dive’Watch now
Panel DiscussionWatch now